Molecular Therapy is the cellular modifications at the molecular level. The study includes areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide- and protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Targeted Therapies uses drugs to target specific molecules (for example, proteins) on the surface of or inside harmful cells. These molecules help send signals that tell cells to grow or divide. By targeting these molecules, the drugs stop the growth and spread of harmful cells while limiting harm to normal cells. Targeted therapies use different types of drugs, and each drug works differently. Researchers are studying different targeted therapies in animals (preclinical testing) and in humans (clinical trials). However, few targeted therapies have been approved for treatment. Targeted therapies may eventually prove to be more effective and less harmful than current treatments.
Related Journals of Molecular Therapy
Translational Biomedicine, Journal of Heavy Metal & Chelation Therapy, Journal of Rare Disorders: Diagnosis & Therapy, Stroke Research & Therapy, Journal of Cellular & Molecular Pathology, Biochemistry & Molecular Biology Journal, Journal of Heavy Metal & Chelation Therapy, Journal of Rare Disorders: Diagnosis & Therapy, Stroke Research & Therapy, Journal of Cellular & Molecular Pathology, Biochemistry & Molecular Biology Journal, Cellular & Molecular Medicine: Open access, Molecular Therapy, Molecular Therapy-Nucleic Acids